Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May-Jun;35(3):1419-1436.
doi: 10.21873/invivo.12394. Epub 2021 Apr 28.

Therapeutic Effect of EPA/DHA Supplementation in Neoplastic and Non-neoplastic Companion Animal Diseases: A Systematic Review

Affiliations

Therapeutic Effect of EPA/DHA Supplementation in Neoplastic and Non-neoplastic Companion Animal Diseases: A Systematic Review

Tomás Rodrigues Magalhães et al. In Vivo. 2021 May-Jun.

Abstract

Background/aim: The aim of this study is to identify and describe randomized controlled studies evaluating the therapeutic effect of EPA and DHA supplementation in companion animal diseases.

Materials and methods: A systematic search was conducted in PubMed database and the information collected was summarized and evaluated according to the risk of bias, using the revised Cochrane tool (RoB2).

Results: Twenty-three studies were eligible for inclusion: twenty performed in dogs and three in cats. A therapeutic benefit was found in canine allergic dermatitis, haircoat disorder, keratoconjunctivitis sicca, valvular disease, and canine and feline osteoarthritis. Dogs diagnosed with chronic heart failure and lymphoma and cats with allergic dermatitis also seem to benefit from supplementation with omega-3 fatty acids, but studies with improved methodological quality are needed to strengthen this evidence.

Conclusion: EPA and DHA supplementation has proven benefits in the adjuvant treatment of various neoplastic and non-neoplastic diseases in dogs and cats.

Keywords: DHA; EPA; Eicosapentaenoic acid; cats; docosahexaenoic acid; dogs; omega-3 fatty acids; review; supplementation.

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflicts of interest with regards to this study.

Figures

Figure 1
Figure 1. PRISMA flowchart of selected studies.
Figure 2
Figure 2. Risk of bias in selected randomized clinical trials: summary plot.
Figure 3
Figure 3. Risk of bias in selected randomized clinical trials: traffic-light plot.

References

    1. Elrod SM, Hofmeister EH. Veterinarians’ attitudes towards use of nutraceuticals. Can J Vet Res. 2019;83(4):291–297. - PMC - PubMed
    1. Bauer JE. The essential nature of dietary omega-3 fatty acids in dogs. J Am Vet Med Assoc. 2016;249(11):1267–1272. doi: 10.2460/javma.249.11.1267. - DOI - PubMed
    1. Bauer JE. Metabolic basis for the essential nature of fatty acids and the unique dietary fatty acid requirements of cats. J Am Vet Med Assoc. 2006;229(11):1729–1732. doi: 10.2460/javma.229.11.1729. - DOI - PubMed
    1. Shahidi F, Ambigaipalan P. Omega-3 polyunsaturated fatty acids and their health benefits. Annu Rev Food Sci Technol. 2018;9:345–381. doi: 10.1146/annurev-food-111317-095850. - DOI - PubMed
    1. Bauer JE. Therapeutic use of fish oils in companion animals. J Am Vet Med Assoc. 2011;239(11):1441–1451. doi: 10.2460/javma.239.11.1441. - DOI - PubMed

Publication types

LinkOut - more resources